Lakeshore Biopharma Co. Ltd.Preferred / convertible
13F holders, Q4 2024 (December 31)18holders −3
1new positions
2sold out
1famous investor
$0.09avg. 13F price*
At the end of Q4 2024, 18 institutions reported holding Lakeshore Biopharma Co. Ltd. in their 13F filings, down 3 from Q3 2024. 1 opened new positions and 2 sold out. The largest holders were LMR Partners LLP ($84K), Valliance Asset Management Ltd ($60K) and Finepoint Capital LP ($49K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Lakeshore Biopharma Co. Ltd.
- CUSIP
- G9845F117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $84K |
| Exits | 2 | $3K |
All 13F filers, Q3 2024 → Q4 2024: 1,052,461 shares bought and 47,275 shares sold, net +1,005,186 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| LMR Partners LLP | — | New | 1,052,461 | $84K |
| Valliance Asset Management Ltd | — | No change | 750,000 | $60K |
| Finepoint Capital LP | — | No change | 489,999 | $49K |
| Athos Capital Ltd | — | No change | 128,981 | $45K |
| Jane Street Group, LLC | — | No change | 498,301 | $40K |
| Bracebridge Capital, LLC | — | No change | 232,323 | $18K |
| Ovata Capital Management Ltd | — | No change | 150,000 | $15K |
| Calamos Advisors LLC | — | No change | 146,040 | $14K |
| Q Global Advisors, LLC | — | No change | 130,600 | $10K |
| Whitebox Advisors LLC | — | No change | 125,000 | $10K |
| D. E. Shaw & Co. | — | No change | 100,000 | $10K |
| Saba Capital Management, L.P. | — | No change | 97,299 | $8K |
| Walleye Capital LLC | — | Reduce -4.9% | 95,030 | $8K |
| Cantor Fitzgerald, L. P. | — | No change | 76,931 | $6K |
| Clear Street LLC | — | No change | 48,168 | $4K |
| SkyView Investment Advisors, LLC | — | No change | 12,210 | $1K |
| Ancora Advisors LLC | — | No change | 5,050 | $401 |
| HGC Investment Management Inc. | — | No change | 5,000 | $397 |
"% of holder's portfolio" is LAKESHORE BIOPHARMA CO LTD's weight in each manager's 13F, not the share of Lakeshore Biopharma Co. Ltd. the manager owns.